sucrose has been researched along with orlistat in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 5 (55.56) | 29.6817 |
2010's | 4 (44.44) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Feinle, C; Fried, M; Otto, B; Rades, T | 1 |
Belowski, D; Herman, ZS; Krysiak, R; Madej, A; Okopień, B | 1 |
Calis, KA; Carobene, SE; Heck, AM; McDuffie, JR; Yanovski, JA | 1 |
Ballaux, D; Mertens, I; Van Gaal, L; Verkade, HJ | 1 |
Gooijert, KE; Havinga, R; Kuipers, F; Oosterloo-Duinkerken, AR; Venekamp-Hoolsema, EE; Verkade, HJ | 1 |
Chapman, IM; Hammond, AJ; Horowitz, M; Tai, K; Wishart, JM | 1 |
Bedros, JR; Medvegy, M; Pados, G; Simonyi, G | 1 |
Borel, P; Caillaud, D; Cano, NJ | 1 |
4 review(s) available for sucrose and orlistat
Article | Year |
---|---|
[Current pharmacotherapy of obesity].
Topics: Adrenergic Agents; Animals; Appetite Depressants; Fatty Acids; Humans; Lactones; Leptin; Lipase; Obesity; Orlistat; Serotonin Agents; Sucrose | 2000 |
Modern, new pharmacotherapy for obesity. A gastrointestinal approach.
Topics: Amylases; Androgens; Anti-Obesity Agents; Citrates; Cyclobutanes; Dietary Fats; Fat Substitutes; Fatty Acids; Glucagon; Glucagon-Like Peptide 1; Glucosidases; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Lipase; Obesity; Orlistat; Peptide Fragments; Protein Precursors; Sucrose | 2004 |
[The pharmacological treatment of obesity: past, present and future].
Topics: Amides; Anti-Obesity Agents; Anticonvulsants; Antidepressive Agents; Basal Metabolism; Benzazepines; Benzoxazines; Body Mass Index; Bridged Bicyclo Compounds, Heterocyclic; Ciliary Neurotrophic Factor; Clinical Trials as Topic; Combined Modality Therapy; Cyclobutanes; Dexfenfluramine; Fatty Acids; Female; Fenfluramine; Glucagon-Like Peptide 1; Human Growth Hormone; Humans; Intestinal Absorption; Lactones; Leptin; Life Style; Liraglutide; Male; Norepinephrine; Obesity; Obesity, Morbid; Orlistat; Piperidines; Pyrazoles; Pyridines; Receptor, Melanocortin, Type 4; Rimonabant; Satiation; Serotonin; Sodium-Glucose Transport Proteins; Sucrose; Thyroid Hormones | 2012 |
Vitamin D bioavailability: state of the art.
Topics: Aging; Biological Availability; Cholecalciferol; Dietary Supplements; Ergocalciferols; Fatty Acids; Food, Fortified; Humans; Intestinal Absorption; Lactones; Orlistat; Risk Factors; Sucrose; Vitamin D | 2015 |
2 trial(s) available for sucrose and orlistat
Article | Year |
---|---|
Fat digestion modulates gastrointestinal sensations induced by gastric distention and duodenal lipid in humans.
Topics: Adult; Cholecystokinin; Dietary Fats; Digestion; Duodenum; Enteral Nutrition; Enzyme Inhibitors; Fat Substitutes; Fatty Acids; Fatty Acids, Nonesterified; Female; Gastric Mucosa; Humans; Hunger; Lactones; Lipase; Male; Orlistat; Pressure; Sensation; Stomach; Sucrose; Triglycerides | 2001 |
Carbohydrate and fat digestion is necessary for maximal suppression of total plasma ghrelin in healthy adults.
Topics: Acarbose; Adolescent; Adult; Dietary Fats; Dietary Sucrose; Digestion; Enzyme Inhibitors; Feedback, Physiological; Female; Gastric Emptying; Ghrelin; Humans; Lactones; Male; Orlistat; Postprandial Period; Reference Values; Sucrose; Young Adult | 2010 |
3 other study(ies) available for sucrose and orlistat
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Additive gastrointestinal effects with concomitant use of olestra and orlistat.
Topics: Adolescent; Anti-Obesity Agents; Clinical Trials as Topic; Digestive System; Drug Interactions; Fat Substitutes; Fatty Acids; Female; Gastrointestinal Diseases; Humans; Lactones; Orlistat; Pilot Projects; Sucrose | 2002 |
Stimulation of fecal fat excretion and the disposal of protoporphyrin in a murine model for erythropoietic protoporphyria.
Topics: Animals; Diet, Fat-Restricted; Dietary Fats; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fat Substitutes; Fatty Acids; Feces; Ferrochelatase; Intestinal Mucosa; Intestines; Lactones; Lipase; Lipid Metabolism; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Orlistat; Protoporphyria, Erythropoietic; Protoporphyrins; Sucrose; Time Factors | 2007 |